W
WLC

Latest

Longevity Medicine News

Research, clinical trials, regulatory updates, and industry analysis from the longevity medicine world.

All longevity clinics diagnostics biomarkers longevity-clinic-comparison longevity-diagnostics clinics regulation best-longevity-clinics longevity-clinics patient safety clinic comparison clinic-comparison evidence-based healthspan industry-news longevity longevity clinic longevity-treatments medical tourism aging research biohacking clinical trials clinical-trials clinique-la-prairie evidence fountain-life longevity-industry longevity-science NAD-therapy peptide-therapy preventive medicine preventive-health progevita aging aging-research ai diagnostics ai-diagnostics biological-age BPC-157 business cleveland-clinic epigenetic-clock executive health executive-health FDA-regulation hospital-longevity-programs innovation lanserhof longevity clinic cost longevity treatments longevity-medical-tourism longevity-medicine longevity-medicine-europe metabolic health NMN NR patient guide plasmapheresis preventive-medicine regenerative medicine research semaglutide sha-wellness-clinic stem cell therapy stem cells US-longevity-clinics affordable-longevity-europe aging frailty AI diagnostics AI-diagnostics AI-drug-discovery ai-medicine allogeneic stem cells Alzheimer-disease AMAALA anti-aging-science anti-aging-treatments ARPA-H Austin-Texas bangkok-longevity-clinics best-longevity-clinics-dubai best-longevity-clinics-europe best-longevity-clinics-spain best-longevity-clinics-switzerland best-longevity-clinics-thailand best-longevity-clinics-usa biograph biological age biological age reversal biological-age-testing biomarker testing biomarker-testing blood-filtering-therapy buchinger-wilhelmi cardiovascular prevention cellular-senescence centenarians chenot-palace Cleveland Clinic compounding-pharmacies cruise-ship-wellness drug-combo dubai-longevity-clinic-cost editorial EMA epigenetic reprogramming epigenetics european longevity clinics european-longevity-clinics european-wellness evidence-based-medicine executive health program cost executive physical cost exosome therapy franchises full-body MRI genomics geroscience glp-1 GLP-1 GLP-1 longevity clinic GLP-1 microdosing health assessment hormone optimization longevity clinic Human Longevity human-longevity-inc industry-trends inflammation investment ipamorelin joe-rogan lepodisiran longevity biotech longevity clinic europe longevity clinic regulation longevity clinic standards longevity health assessment longevity medicine longevity technology longevity-clinic-cost longevity-clinic-europe longevity-clinic-guide longevity-clinic-trends longevity-clinic-uae longevity-clinics-europe longevity-clinics-expansion longevity-expansion longevity-intelligence longevity-medicine-asia longevity-ranking longevity-technology longevity-testing longevity-tourism Lp(a) luxury-longevity luxury-wellness-europe marketing mayo-clinic media medical-tourism-thailand medical-wellness-switzerland men health menopause hormone therapy MSC therapy mTOR inhibitors multiomics muvalaplin NAD+ neurodegenerative-disease Niagen oxytocin palazzo-fiuggi peptide therapy peptides performance pharmaceutical-industry prevention preventive health privacy Progevita programs proteomics protocols rapamycin regenerative regenerative-medicine regenerative-medicine-dubai regulatory-policy risk Saudi-Arabia screening senolytics SHA Wellness Spain sports medicine startups stem cell exosomes swiss-longevity-clinics testosterone replacement therapy TGF-beta therapeutic plasma exchange therapeutic-fasting tirzepatide TPE treatment-comparison treatments TRT longevity clinic United States UT Health San Antonio VO2-max Ways2Well wellness
Lilly: Lepodisiran Phase 2 ALPACA results

Lepodisiran, Muvalaplin, and the Lp(a) Moment: What New Cholesterol Drugs Mean for Longevity Clinics

Lepodisiran and muvalaplin are investigational Lp(a)-lowering drugs. For longevity clinics, the real 2026 action is smarter inherited cardiovascular risk screening.

Lp(a) lepodisiran muvalaplin